Reports for NATCO PHARMA (CANADA) INC

Company Name

NATCO PHARMA (CANADA) INC

Totals

Shortage reports

26
Actual shortage: 5 (19%)
Anticipated shortage: 5 (19%)
Avoided shortage: 0 (0%)
Resolved: 16 (62%)

Discontinuation Reports

0
To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

1 (4%)

Overdue reports

0 (0%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NAT-PREGABALIN 225MG CAPSULE Actual shortage 2023-05-17 2024-02-02 192650
NATCO-CITALOPRAM 10MG TABLET Resolved 2018-11-23 2019-02-04 67518
NAT-DONEPEZIL 5MG TABLET Resolved 2018-07-13 2020-10-26 55625
NAT-DONEPEZIL 5MG TABLET Resolved 2024-02-02 2024-02-21 218262
NAT-DONEPEZIL 5MG TABLET Anticipated shortage 2024-04-29 2024-04-29 226585
NAT-DONEPEZIL 10MG TABLET Resolved 2018-07-13 2020-10-26 55630
NAT-ERLOTINIB 25MG TABLET Actual shortage 2020-12-03 2024-02-02 129536
NAT-ERLOTINIB 100MG TABLET Actual shortage 2020-12-03 2024-02-02 129550
NAT-ERLOTINIB 150MG TABLET Actual shortage 2020-12-03 2024-02-02 129553
NAT-ESCITALOPRAM 10MG TABLET Resolved 2019-02-15 2020-10-26 75793
NAT-ESCITALOPRAM 20MG TABLET Resolved 2019-02-15 2020-10-26 75799
NAT-ESCITALOPRAM 20MG TABLET Actual shortage 2024-02-02 2024-04-08 218258
NAT-EVEROLIMUS 2.5MG TABLET Anticipated shortage 2024-04-29 2024-04-29 226575
NAT-LEVETIRACETAM 250MG TABLET Resolved 2019-02-15 2022-07-01 75810
NAT-LEVETIRACETAM 500MG TABLET Resolved 2018-10-19 2020-10-26 64878
NAT-LEVETIRACETAM 750MG TABLET Resolved 2019-04-17 2021-10-15 81921
NAT-MONTELUKAST 4MG TABLET (CHEWABLE) Anticipated shortage 2024-04-29 2024-04-29 226579
NAT-MONTELUKAST 5MG TABLET (CHEWABLE) Anticipated shortage 2024-04-29 2024-04-29 226582
NAT-QUETIAPINE 25MG TABLET Resolved 2018-10-31 2022-07-01 65944
NAT-QUETIAPINE 100MG TABLET Resolved 2019-04-17 2022-07-01 81900

Showing 1 to 20 of 26

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0